Drug intelligence / Profile preview

Visine for Contacts

Development stage: Phase 2
Lead developer: Kenvue
Modality: Small Molecules
Administration: Ophthalmic

Overview

**Visine for Contacts** is a sterile lubricating and rewetting ophthalmic solution intended for use while wearing daily-wear and extended-wear soft hydrophilic contact lenses. The formulation contains hypromellose and glycerin in an isotonic borate-buffered solution, with potassium sorbate and edetate disodium as preservatives. It is used to moisten contact lenses, refresh and soothe the eyes, and help remove particulate matter associated with lens discomfort or transient blurring. The product was originally cleared in the United States as a soft contact-lens accessory product and was evaluated as a rewetting-drop comparator in a completed Phase 4 study in contact lens-related dry eye.

Brand names: Visine for Contacts
Other names: Visine for Contacts Lubricating + Rewetting Drops

Targets

ADRA1A (α1A)

Beyond the preview

Go deeper on Visine for Contacts.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Visine for Contacts.